Federal grants to Reveal Pharmaceuticals, Inc
Reveal Pharmaceuticals, Inc in Cambridge, Massachusetts received $11.7 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Cancer Treatment Research, with $6.1 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$11.7 million
- Awards6
- Awarded in FY 2025$0
- Largest award$4.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $2.4 million |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 3 | $4.0 million |
| FY 2024 | 3 | $4.0 million |
| FY 2025 | 0 | $0 |
Programs that fund Reveal Pharmaceuticals, Inc
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 2 | $6.1 million |
| Cardiovascular Diseases Research | 2 | $2.4 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $2.2 million |
| Cancer Detection and Diagnosis Research | 1 | $999,330 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $11.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Manganese based mri contrast agent - gadolinium (GD)-based mri contrast agents (GBCAS) are used in clinical magnetic resonance imaging (MRI) for cancer detection and staging, particularly of primary and metastatic brain cancers. However, there are concerns about the potential long-term toxicity of g | Cancer Treatment Research | June 6, 2023 | $4.0 million |
| Fibrogenesis targeted manganese based mri contrast agent - nonalcoholic fatty liver disease (NAFLD) affects an estimated 20-30% of adults in the western world. Most nafld is benign, but up to 30% of nafld patients will develop a progressive form of fatty liver termed nonalcoholic steatohepatitis (na | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 15, 2022 | $2.2 million |
| Manganese-based contrast agent for cardiovascular mri - abstract cardiovascular disease is the leading cause of morbidity and death, representing 1 in 3 deaths in the united states, and 18.6 million deaths globally annually. Contrast enhanced magnetic resonance imaging (MRI) and computed tomography | Cardiovascular Diseases Research | May 23, 2023 | $2.1 million |
| Manganese based mri contrast agent - first in human clinical trial - project summary gadolinium (GD)-based mri contrast agents (GBCAS) are widely used in clinical magnetic resonance imaging (MRI), especially for the detection and staging of cancers. However, in 2006 it was discovered that gbcas can | Cancer Treatment Research | September 24, 2021 | $2.1 million |
| Liver specific manganese based mri contrast agent | Cancer Detection and Diagnosis Research | March 17, 2021 | $999,330 |
| Manganese-based contrast agent for cardiovascular mri - project summary. Ischemic heart disease is the leading cause of morbidity and death in the united states representing 1 in 3 american deaths and globally (17 million deaths annually). Contrast enhanced computed tomography (CT) and magnetic reso | Cardiovascular Diseases Research | December 11, 2020 | $300,000 |
Questions people ask
How much federal grant money does Reveal Pharmaceuticals, Inc get?
$11.7 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Reveal Pharmaceuticals, Inc the most?
The Department of Health and Human Services, with $11.7 million in 6 awards.
What is Reveal Pharmaceuticals, Inc's largest federal grant?
$4.0 million under Cancer Treatment Research, with its first action in the period on June 6, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Reveal Pharmaceuticals, Inc?
Its largest are Cancer Treatment Research, Cardiovascular Diseases Research and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Cambridge
- Massachusetts Institute of Technology
- President and Fellows of Harvard College
- The Broad Institute, Inc
- National Bureau of Economic Research Inc
- Smithsonian Institution
- City of Cambridge
- Whitehead Institute for Biomedical Research
- Ada Forsyth Institute, Inc.
Largest federal grant recipients in Massachusetts · Federal grants in Massachusetts